Pricing Log in Create free account

Enanta Pharmaceuticals, Inc. (ENTA) vs Turn Therapeutics Inc. (TTRX)

Enanta Pharmaceuticals, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Turn Therapeutics Inc. are of similar size ($345.3M and $334.1M). Turn Therapeutics Inc. has the higher net margin (0.00% vs −96.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Enanta Pharmaceuticals, Inc. leads on 6 and Turn Therapeutics Inc. on 6.

Valuation

Metric ENTA TTRX Biotechnology median
P/E n/m n/m 8.50
P/S 4.95 n/m 9.71
P/B 3.19 458.38 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.04 n/m 9.21
Earnings yield (21.71%) (2.74%) (33.15%)
Free cash flow yield (11.44%) (1.42%) (25.50%)

Profitability

Metric ENTA TTRX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (89.99%) 0.00% 0.00%
Net margin (96.89%) 0.00% 0.00%
Free cash flow margin (56.60%) 0.00% 0.00%
Return on equity (70.12%) (3,315.33%) (56.36%)
Return on assets (21.15%) (99.59%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENTA TTRX Biotechnology median
Revenue growth (TTM) 0.70% — 6.02%
EPS growth (last fiscal year) 29.93% (80.72%) 30.26%
Revenue growth, 5-year CAGR (11.81%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ENTA TTRX Biotechnology median
Debt to equity 0.00 8.83 0.00
Current ratio 3.76 1.19 4.72
Net debt to EBITDA 2.35 0.96 0.96

Dividend

Metric ENTA TTRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENTA TTRX Biotechnology median
Market cap 334.07m 345.25m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack